Recently analysts working for a variety of stock market brokerages have changed their consensus ratings and price targets on shares of Diplomat Pharmacy, Inc. (NYSE:DPLO).
Recent analyst ratings and price targets:
05/11/2016 – Diplomat Pharmacy, Inc. had its “neutral” rating reiterated by analysts at Mizuho. They now have a USD 33 price target on the stock.
05/10/2016 – Diplomat Pharmacy, Inc. had its “outperform” rating reiterated by analysts at Leerink Swann. They now have a USD 36 price target on the stock.
04/18/2016 – Avondale Partners began new coverage on Diplomat Pharmacy, Inc. giving the company a “market outperform” rating. They now have a USD 38 price target on the stock.
03/16/2016 – Credit Suisse began new coverage on Diplomat Pharmacy, Inc. giving the company a “neutral” rating. They now have a USD 29 price target on the stock.
03/01/2016 – Diplomat Pharmacy, Inc. was downgraded to “neutral” by analysts at JP Morgan. They now have a USD 30 price target on the stock.
01/06/2016 – Barclays began new coverage on Diplomat Pharmacy, Inc. giving the company a “overweight” rating. They now have a USD 41 price target on the stock.
11/04/2015 – Diplomat Pharmacy, Inc. had its “outperform” rating reiterated by analysts at Raymond James. They now have a USD 45 price target on the stock.
10/21/2015 – UBS began new coverage on Diplomat Pharmacy, Inc. giving the company a “buy” rating. They now have a USD 35 price target on the stock.
10/14/2015 – Diplomat Pharmacy, Inc. was upgraded to “neutral” by analysts at Bank of America Merrill Lynch. They now have a USD 32 price target on the stock.
10/02/2015 – Diplomat Pharmacy, Inc. was downgraded to “equal-weight” by analysts at Morgan Stanley. They now have a USD 31 price target on the stock.
09/23/2015 – Diplomat Pharmacy, Inc. had its “outperform” rating reiterated by analysts at William Blair.
06/22/2015 – Diplomat Pharmacy, Inc. had its “outperform” rating reiterated by analysts at Robert W. Baird. They now have a USD 50 price target on the stock.
05/09/2015 – Diplomat Pharmacy, Inc. was upgraded to “hold” by analysts at Zacks.
Diplomat Pharmacy, Inc. has a 50 day moving average of 29.69 and a 200 day moving average of 30.81. The stock’s market capitalization is 1.88B, it has a 52-week low of 22.41 and a 52-week high of 52.33.
The share price of the company (NYSE:DPLO) was down -3.51%, with a high of 30.26 during the day and the volume of Diplomat Pharmacy, Inc. shares traded was 419407.
Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with MarketBeat.com’s FREE daily email newsletter.